Skip to main content
SpringerLink
Log in

Therapieverfahren

  • Chapter
Herzrhythmusstörungen

  • 4661 Accesses

Zusammenfassung

Grundsätzlich sind 2 Formen von Rhythmusstörungen behandlungsbedürftig. Nämlich solche, die zu subjektiven Symptomen führen, und Arrhythmien, die mit einer prognostischen Belastung des Patienten verbunden sind. Zunächst ist zu fragen, inwieweit das klinische Bild tatsächlich durch eine Rhythmusstörung bestimmt ist. Hier werden Arzt wie Patient häufig fehlgeleitet. Herzrasen, Palpitationen, Schwindel werden nicht selten fälschlich als arrhythmiebedingt gewertet. Untersuchungen mit Langzeit-EKGRegistrierung und Telemetrie haben gezeigt, dass Palpitationen in über 50% der Fälle nicht durch Arrhythmien bedingt sind. Umgekehrt verursachten tatsächlich vorhandene Herzrhythmusstörungen bei weniger als der Hälfte der Patienten eine klinische Symptomatik (Senges u. Czygan 1985). Zwischen den subjektiven Beschwerden und der tatsächlichen Präsenz von Herzrhythmusstörungen besteht daher nur eine unsichere Beziehung.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Bergbauer M, Sabin G (1983) Hämodynamische Langzeitresultate der biofokalen Schrittmacherstimulation. Dtsch Med Wochenschr 108:545

    CAS  PubMed  Google Scholar 

  • Brandfonbrenner M, Landowne M, Schock NW (1955) Changes in cardiac output with age. Circulation 12:557

    Google Scholar 

  • Crozier IG, Ikram H, Nicolls MG, Espiner EA, Yandle TG (1987) Atrial natriuretic peptide in spontaneous tachycardias. Br Heart J 58:96

    CAS  PubMed  Google Scholar 

  • Lüderitz B (1989) Hämodynamische Gesichtspunkte bei der Therapie mit Antiarrhythmika. Dtsch Med Wochenschr 114:30–33

    PubMed  Google Scholar 

  • Neyses L, Nitsch L, Manz M, Korus HC, Tüttenberg HP, Lüderitz B (1988) Bei essentieller Hypertonie wird der Spiegel des atrialen natriuretischen Peptids (ANP) durch das Ausmaß der Herzbeteiligung bestimmt. Z Kardiol 77 Suppl 1:73

    Google Scholar 

  • Nitsch J, Seiderer M, Büll U, Lüderitz B (1982) Individuelle Schrittmacherprogrammierung durch äquilibrium Ventrikulographie (ÄRNV). Z Kardiol 71:240

    Google Scholar 

  • Nitsch J, Seiderer M, Büll U, Lüderitz B (1983) Auswirkung unterschiedlicher Schrittmacherstimulation auf linksventrikuläre Volumendaten. Untersuchungen mit der Radionuklid-Ventrikulographie. Z Kardiol 72:178

    Google Scholar 

  • Robinson S (1939) Experimental studies of physical fitness in relation to age. Arbeitsphysiologie 10:251

    Google Scholar 

Literatur

  • AFFIRM Investigators (2004) Relationships Between Sinus Rhythm, Treatment, and Survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study. Circulation 109(12):1509–13

    Google Scholar 

  • Aimond F, Beck L, Gautier P, Cherif OK, Davy JM, Lorente P, Nisato D, Vassort G (2000) Cellular and in vivo electrophysiological effects of dronedarone in normal and postmyocardial infarcted rats. J Pharmacol Exp Ther 292(1):415–24

    CAS  PubMed  Google Scholar 

  • Altomare C, Barbuti A, Viscomi C, Baruscotti M, DiFrancesco D (2000) Effects of dronedarone on acetylcholine-activated current in rabbit SAN cells. Br J Pharmacol 130(6):1315–20

    CAS  PubMed  Google Scholar 

  • Altura BM, Altura BT (1984) Interactions of magnesium and potassium on cardiac and vascular smooth muscle. Magnesium 3:178

    Google Scholar 

  • Anderson JL, Askins JC, Gilbert EM et al. (1986) Multicenter trial of sotalol for suppression of frequent, complex ventricular arrhythmias: A double-blind, randomized, placebo-controlled evaluation of two doses. J Am Coll Cardiol 8:752–762

    CAS  PubMed  Google Scholar 

  • Anonymus (2005) New antiarrhythmic provides option for atrial fibrillation. News coverage from the American Heart Association Annual Meeting. Dallas, USA, 13.–16. Nov. 2005. Internet: http://www. rsinewsrxreportingfrom.com/content.asp?myid=44&tid=391

    Google Scholar 

  • Bashir V, Wong C, Nathan AW, Cobbe SM, Campbell RW, Rasmussen HS (1992) Efficacy and safety of dofetilide, a new class III antiarrhythmic agent in recurrent ventricular tachycardia [abstract]. Br Heart J 68:116

    Google Scholar 

  • Beck CS, Pritchard WH, Feil HS (1947) Ventricular fibrillation of long duration abolished by electric shock. J Am Med Assoc 135:985–986

    CAS  PubMed  Google Scholar 

  • Belz GG, Bender F (1974) Therapie der Herzrhythmusstörungen mit Verapamil. Fischer, Stuttgart

    Google Scholar 

  • Ben-David J, Zipes DP (1993) Torsades de pointes and proarrhythmia. Lancet 341:1578–1582

    CAS  PubMed  Google Scholar 

  • Bender F, Bachour G, Gradaus D (1980) Behandlung von Herzrhythmusstörungen und Hypertonie mit Calciumantagonisten. In: Fleckenstein A, Roskamm H (Hrsg) Calcium-Antagonisten. Springer, Berlin Heidelberg New York

    Google Scholar 

  • Bender F, Hartman C, Brisse B, Wichmann B (1975) Therapie der Bradykardie mit einem Atropinester. Z Kardiol 64:329

    CAS  PubMed  Google Scholar 

  • Bexton RS, Camm AJ (1982) Drugs with a class III antiarrhythmic action. Pharmacol Ther 17:315

    CAS  PubMed  Google Scholar 

  • Biaggioni I, Olafsson B, Robertson RM, Hollister AS, Robertson D (1987) Cardiovascular and respiratory effects of adenosine in conscious man: evidence for chemoreceptor activation. Circ Res 61:779–786

    CAS  PubMed  Google Scholar 

  • Bolte H-D, Bergmann M, Tebbe U (1976) Unterschiedliche Wirkungen eines neuen Antiarrhythmikums (Propafenon) auf Purkinje-und Arbeitsmyokardfasern. Verh Dtsch Ges Inn Med 82:1239

    PubMed  Google Scholar 

  • Borders-Hemphill V (2009) Concurrent use of statius and amiodarone. Consult Pharm 24:372–379

    PubMed  Google Scholar 

  • Borggrefe M, Breithardt G (1985) Elektrophysiologische Wirkung von Sotalol bei supraventrikulären Tachykardien. Z Kardiol 74:506

    CAS  PubMed  Google Scholar 

  • Branch RA, Shand DG, Wilkinson GR, Nies AS (1973) Hemodynamic drug interaction: The reduction of lidocaine clearance by dl-propranolol. An example of hemodynamic drug interaction. J Pharmacol Exp Ther 184:515

    CAS  Google Scholar 

  • Brisse B (1981) Therapie bradykarder Rhythmusstörungen. In: Lüderitz B (Hrsg) Ventrikuläre Herzrhythmusstörungen. Pathophysiologie-Klinik — Therapie. Springer, Berlin Heidelberg New York

    Google Scholar 

  • Brodsky MA, Chough SP, Byron JA, Capparelli EV, Orlov MV, Caudillo G (1992) Adjuvant metoprolol improves efficacy of class I antiarrhythmic drugs in patients with inducible sustained monomorphic ventricular tachycardia. Am Heart J 124:629

    CAS  PubMed  Google Scholar 

  • Burkart F, Pfisterer M, Kowski W, Follath F, Burckhardt D (1990) Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel Antiarrhythmic Study of Infarct Survival (BASIS) J Am Coll Cardiol 16:1711–1718

    CAS  PubMed  Google Scholar 

  • Cabalay MS, Taylor DM, Knott JC et al. (2010) Recent Coffeine ingestion reduces adenosine efficacy in the treatment of paroxysmal supraventricular tachycardia. Acad Emerg Med: e-published

    Google Scholar 

  • Cairns JA, Connolly SJ, Robert R, Gent M, for the Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators(1997) Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Lancet 349:675–682

    CAS  PubMed  Google Scholar 

  • Carrusco HA, Fuenmayer A, Barboza JS, Gonzalez G (1978) Effect of verapamil on normal sinoatrial node function and on sick sinus syndrome. Am Heart J 96:760

    Google Scholar 

  • Celestino D, Medei E, Moro S, Elizari MV, Sicouri S (2007) Acute in vitro effects of dronedarone, an iodine-free derivative, and amiodarone, on the rabbit sinoatrial node automaticity: a comparative study. J Cardiovasc Pharmacol Ther 12(3):248–57

    CAS  PubMed  Google Scholar 

  • Ceremuzynski L, Kleczar E, Kreminska-Pakula M et al. (1992) Effect of amiodarone on mortality after myocardial infarction: A double-blind, placebo controlled pilot study. J Am Coll Cardiol 20:1056–1062

    CAS  PubMed  Google Scholar 

  • Chatelain P, Meysmans L, Matteazzi JR, Beaufort P, Clinet M (1995) Interaction of the antiarrhythmic agents SR 33589 and amiodarone with the beta-adrenoceptor and adenylate cyclase in rat heart. Br J Pharmacol 116(3):1949–56

    CAS  PubMed  Google Scholar 

  • Clinical Trials Database (2007a) ATHENA: A Trial With Dronedarone to Prevent Hospitalization or Death in Patients With Atrial Fibrillation. ClinicalTrials.gov Identifier: NCT00174785. Internet: http://www. clinicaltrials.gov/ct/gui/show/NCT00174785

    Google Scholar 

  • Clinical Trials Database (2007b) Efficacy & Safety of Dronedarone Versus Amiodarone for the Maintenance of Sinus Rhythm in Patients With Atrial Fibrillation (DIONYSOS). ClinicalTrials.gov Identifier: NCT00489736

    Google Scholar 

  • Connolly S, Roy D et al. (2004) Randomized trials of dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter: EURIDIS and ADONIS. Can J Cardiol 20(Suppl. D):197–8

    Google Scholar 

  • Connolly SJ, Crijns H J G M, Torp-Pedersen C (2009) Analysis of Stroke in ATHENA: A Placebo-controlled, Double-Blind, Parallel-Arm Trial to Assess the Efficacy of Dronedarone 400 mg BID for the Prevention of Cardiovascular Hospitalization or Death From Any Cause in Patients With Atrial Fibrillation/Atrial Flutter. Circulation 120:1174–1180

    CAS  PubMed  Google Scholar 

  • Copeti R, Proculumer A, Pillinini P et al. (2005) Life treatening proarrhythmia in a patient with orthodronic AV tachycardia treated with lowdone adenosine. J Cardiovasc Electrophysil 16:106

    Google Scholar 

  • Coplen SE, Antman EM, Berlin JA, Hewitt P, Chalmers TC (1990) Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. Circulation 82:1106

    CAS  PubMed  Google Scholar 

  • Damy T, Pousset F, Caplain H, Hulot JS, Lechat P (2004) Pharmacokinetic and pharmacodynamic interactions between metoprolol and dronedarone in extensive and poor CYP2D6 metabolizers healthy subjects. Fundam Clin Pharmacol 18(1):113–23

    CAS  PubMed  Google Scholar 

  • Dany F, Liozon F, Goudoud JC, Castel JP, Michel JP, Marsaud P, Merle L, Dallocchio M (1980) Torsade de pointes et arythmies ventriculaires graves par administration parentérales de vincamine. Arch Mal Coeur 73:298

    CAS  PubMed  Google Scholar 

  • Davy J (2005) Dronedarone demonstrates additional rate control on top of standard pharmacotherapies in the treatment of atrial fibrillation [abstract 2737]. Presentation bei Annual Meeting of the American Heart Association 2005

    Google Scholar 

  • Davy JM, Herold M, Haglund C et al. (2008) Dronedarone for the control of ventricular rate in permanent atricl fibrillation. Am J Heart J 156: 257–259

    Google Scholar 

  • DeCarlo, Sprouse G, LaRosa JC (1986) Serum magnesium levels in symptomatic atrial fibrillation and their relation to rhythm control by intravenous digoxin. Am J Cardiol 57:956

    Google Scholar 

  • DiMarco JP, Miles W, Akhtar M et al. (1990) Adenosine for paroxysmal supraventricular tachycardia: dose ranging and comparison with verapamil. Ann Intern Med 113:104–110

    CAS  PubMed  Google Scholar 

  • Djandjighian L, Planchenault J, Finance O, Pastor G, Gautier P, Nisato D (2000) Hemodynamic and antiadrenergic effects of dronedarone and amiodarone in animals with a healed myocardial infarction. J Cardiovasc Pharmacol 36(3):376–83

    CAS  PubMed  Google Scholar 

  • Doggrell SA, Hancox JC (2004) Dronedarone: an amiodarone analogue. Expert Opin Investig Drugs 13(4):415–26

    CAS  PubMed  Google Scholar 

  • Duff JH, Roden DM, Maffucci RJ, Vesper BS, Conard GJ, Higgins SB, Oates JA, Smith RF, Woosley RL (1981) Suppression of resistant ventricular arrhythmias by twice daily dosing of flecainide. Am J Cardiol 48:1133–1140

    CAS  PubMed  Google Scholar 

  • Duffy CE, Swiryn S, Bauernfeind RA, Strasberg B, Palileo E, Rosen KM (1983) Inducible sustained ventricular tachycardia refractory to individual class I drugs: effect of adding a second class I drug. Am Heart J 106:450

    CAS  PubMed  Google Scholar 

  • Eloff BC, Gilat E, Wan X, Rosenbaum DS (2003) Pharmacological modulation of cardiac gap junctions to enhance cardiac conduction: evidence supporting a novel target for antiarrhythmic therapy. Circulation 108:3157–3163

    CAS  PubMed  Google Scholar 

  • Elonen E, Neuvonen PJ, Tarssanen L, Kala R (1979) Sotalol intoxication with prolonged Q-T interval and severe tachyarrhythmias. Br Med J 1:1184

    CAS  PubMed  Google Scholar 

  • Falk RH, Pollak A, Singh SN, Friedrich T, for the intravenous dofetilide investigators (1997) Intravenous dofetilide, a class III antiarrhythmic agent, for the termination of sustained atrial fibrillation or flutter. J Am Coll Cardiol 29:385–390

    CAS  PubMed  Google Scholar 

  • Fetsch T, Bauer P, Engberding R et al. (2004) Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial. Eur Heart J 25:1385–1394

    PubMed  Google Scholar 

  • Finance O, Manning A, Chatelain P (1995) Effects of a new amiodaronelike agent, SR 33589, in comparison to amiodarone, D,L-sotalol, and lignocaine, on ischemia-induced ventricular arrhythmias in anesthetized pigs. J Cardiovasc Pharmacol 26(4):570–6

    CAS  PubMed  Google Scholar 

  • Follath F, Heierli B, Wenk M (1980) Praktische Bedeutung der Serumkonzentrationsmessung bei der Therapie mit Antiarrhythmika. In: Sommer R (Hrsg) Kontrolle der Plasmaspiegel von Pharmaka. Thieme, Stuttgart

    Google Scholar 

  • Fragakis N, Bikias A, Delithanasis I et al. (2009) Acute beta-adrenoceptor blockade improves efficacy of ibutilide in conversion of atrial fibrillation with a rapid ventricular rate. Europace 11:70–74

    PubMed  Google Scholar 

  • Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S, Smith SC, Jr., Jacobs AK, Adams CD, Anderson JL, Antman EM, Halperin JL, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel B, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL (2006) ACC/AHA/ ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). J Am Coll Cardiol 48(4): e149–246

    Google Scholar 

  • Gautier P, Guillemare E, Marion A, Bertrand JP, Tourneur Y, Nisato D (2003) Electrophysiologic characterization of dronedarone in guinea pig ventricular cells. J Cardiovasc Pharmacol 41(2):191–202

    CAS  PubMed  Google Scholar 

  • Gibson D, Sowton E (1969) The use of beta-adrenergic receptor blocking drugs in dysrhythmias. Prog Cardiovasc Dis 12:16

    CAS  PubMed  Google Scholar 

  • Giudici MC, Fischer WJ, Cervantes DC et al. (2008) Ibutilide therapy for atrial fibrillation: 5 years experience in a community hospitals. J Cardiovasc Nurs 23:484–488

    PubMed  Google Scholar 

  • Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE (2001) Prevalence of Diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the anticoagulation and risk factors In Atrial Fibrillation (ATRIA) Study. JAMA 285(18):2370–5

    CAS  PubMed  Google Scholar 

  • Greenspan AM, Spielman SR, Webb CR, Sokoloff NM, Rae AP, Horowitz LN (1985) Efficacy of combination therapy with mexiletine and a type IA agent for inducible ventricular tachyarrhythmias secondary to coronary artery disease. Am J Cardiol 56:277

    CAS  PubMed  Google Scholar 

  • Guerra JM, Everett TH, Lee KW et al. (2006) Effects of the gap junction modifier rotigaptide (ZP123) on atrial conduction and vulnerability to atrial fibrillation. Circulation 114:110–118

    CAS  PubMed  Google Scholar 

  • Guillemare E, Marion A, Nisato D, Gautier P (2000) Inhibitory effects of dronedarone on muscarinic K+ current in guinea pig atrial cells. J Cardiovasc Pharmacol 36(6):802–5

    CAS  PubMed  Google Scholar 

  • Gülker H, Haverkamp W, Hindricks G (1992) Leitfaden zur Therapie der Herzrhythmusstörungen, 2. Aufl. DeGruyter, Berlin

    Google Scholar 

  • Gupta A, Lawrence AT, Krishnan K et al. (2007) Current concepts in the mechanisms and management of drug-induced QT prolongation and torsade de pointes. Am J Heart J 153:891–899

    Google Scholar 

  • Haap K, Antoni H (1978) Mexiletin — Tierexperimentelle Befunde über die antiarrhythmischen und elektrophysiologischen Effekte am Herzen. Klin Wochenschr 56:169

    CAS  PubMed  Google Scholar 

  • Harvly MG, Safih S, Wallace M (2007) Adenosine unduced complete heratblock: not so transient. Emergency Medicine Australia 19:559–562

    Google Scholar 

  • Heuer H, Gülker H, Müller US, Bender F (1985) Erhöhte antiarrhythmische Wirksamkeit der Kombination Flecainid/Sotalol und Propafenon/Sotalol bei ventrikulären Arrhythmien. Z Kardiol 74:13 (Abstract)

    Google Scholar 

  • Heufelder A, Wiersing WM (1999) Störungen der Schildrüsenfunktion durch Amiodaron. Deutsches Ärzteblatt 13:A853–860

    Google Scholar 

  • Hodeige D, Heyndrickx JP, Chatelain P, Manning A (1995) SR 33589, a new amiodarone-like antiarrhythmic agent: anti-adrenoceptor activity in anaesthetized and conscious dogs. Eur J Pharmacol 279(1):25–32

    CAS  PubMed  Google Scholar 

  • Hohnloser S, Crijns HJM, van Eickels M et al. (2009) Effect of dronedarone on cardiovascular events in atrial fibrillation. New England Journal of Medicine 360:668–78

    CAS  PubMed  Google Scholar 

  • Hohnloser SH, Dorian P, Roberts R et al. (2006) Effect of amiodarone and sotalol on ventricular defibrillation threshold: the optimal pharmacological therapy in cardioverter defibrillator patients (OPTIC) trial. Circulation 114:104–109

    CAS  PubMed  Google Scholar 

  • Hohnloser SH, Klingenheben T, Singh BN (1994) Amiodarone-associated proarrhythmic effects. A review with special reference to torsade de pointes tachycardia. Ann Intern Med 121(7):529–35

    CAS  PubMed  Google Scholar 

  • Hohnloser SH, Kuck KH, Lilienthal J (2000) Rhythm or rate control in atrial fibrillation — Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial. Lancet 356(9244):1789–94

    CAS  PubMed  Google Scholar 

  • Hondeghem LM, Katzung BG (1980) Test of a model of antiarrhythmic drug action. Circulation 61:1217

    CAS  PubMed  Google Scholar 

  • Hondeghem LM, Synders DJ (1990) Class III antiarrhythmic agents have a lot of potential but a long way to go. Circulation 81:686

    CAS  PubMed  Google Scholar 

  • Honerjäger P (1989) Zusammenhänge zwischen elektrischen und mechanischen Herzwirkungen von Antiarrhythmika. In: Schmidt G (Hrsg) Antiarrhythmische Therapie. Kardiodepressive Nebenwirkungen. Schattauer, Stuttgart New York, S 1–6

    Google Scholar 

  • ISIS Collaborative Group (1993) ISIS-4: Randomised study of intravenous magnesium in over 50 000 patients with suspected acute myocardial infarction. Circulation 88 (Suppl 10):I–292

    Google Scholar 

  • Kathofer S, Thomas D, Karle CA (2005) The novel antiarrhythmic drug dronedarone: comparison with amiodarone. Cardiovasc Drug Rev 23(3):217–30

    CAS  PubMed  Google Scholar 

  • Kawai L, Konishi T, Matsuyama E, Okazaki H (1981) Comparative effects of three calcium antagonists, diltiazem, verapamil and nifedipine, on the sinoatrial and atrioventricular node. Circulation 63:1053

    Google Scholar 

  • Kerr C, Connolly S, Kowey P et al. (2006) Efficacy of azimilide for the maintenance of sinus rhythm in patients with paroxysmal atrial fibrillation in the presence of and absence of structural heart disease. Am J Cardiol 98:215–218

    CAS  PubMed  Google Scholar 

  • Kessler KM, Lowenthal DT, Warner H, Gibson T, Brigge W, Reidenberg MM (1974) Quinidine elimination in patients with congestive heart failure or poor renal function. N Engl J Med 290:706

    CAS  PubMed  Google Scholar 

  • Kleinsorge H (1959) Klinische Untersuchungen über die Wirkungsweise des Rauwolfia-Alkaloids Ajmalin bei Herzrhythmusstörungen, insbesondere der Extrasystolie. Med Klin 10:409–416

    Google Scholar 

  • Kober L, Torp-Pedersen C, McMurray J J, et al. (2008) Increased mortality after dronedarone therapy for severe heart failure. N Engl J Med 358:2678–2687

    PubMed  Google Scholar 

  • Koster RW, Dunning AJ (1985) Intramuscular lidocaine for preventation of lethal arrhythmias in the prehospitalization phase of acute myocardial infarction. N Engl Med 31:1106

    Google Scholar 

  • Kowey P (1997) Ibutilide for atrial fibrillation. Circulation 96:370

    Google Scholar 

  • Kowey P (2004) Preliminary data show dronedarone safer alternative to amiodarone. Late-breaking clinal trial session. 25. Jahrestagung der Heart Rhythm Society. San Francisco

    Google Scholar 

  • Kowey PR, Dorian P, Mitchell LB et al. (2009) Vernakalant hydrochloride for the rapid conversion of atrial fibrillation after cardiac surgery: a randomised, double-blind, placebo-controlled trial. Circ Arrhythm Electrophysiol 2:652–659

    PubMed  Google Scholar 

  • Kozlowski D, Budrejko S, Lip GY et al. (2009) Vernakalant hydrochloride for the treatement of atrial fibrillation. Expert Opin Investig Drugs 18:1929–1937

    CAS  PubMed  Google Scholar 

  • Kuck K-H, Kunze KP, Roewer N, Bleifeld W (1985) Sotalol-induced torsade de pointes. Am Heart J 107:179

    Google Scholar 

  • Kühlkamp V, Haasis R, Seipel L (1988) Flecainid-induzierte Hepatitis. Z Kardiol 77:678–680

    PubMed  Google Scholar 

  • Lafuente-Lafuente C, Mouly S, Longas-Tejero MA, Mahe I, Bergmann JF (2006) Antiarrhythmic drugs for maintaining sinus rhythm after cardioversion of atrial fibrillation: a systematic review of randomized controlled trials. Arch Intern Med 166(7):719–28

    CAS  PubMed  Google Scholar 

  • Lalevee N, Nargeot J, Barrere-Lemaire S, Gautier P, Richard S (2003) Effects of amiodarone and dronedarone on voltage-dependent sodium current in human cardiomyocytes. J Cardiovasc Electrophysiol 14(8):885–90

    PubMed  Google Scholar 

  • Lee TH, Friedmann PL, Goldman L, Stone PH, Antman EM (1984) Sinus arrest and hypotension with combined amiodarone-diltiazem therapy. Am Heart J 109:163

    Google Scholar 

  • Levine JH, Michael JR, Guarnieri T (1985) Treatment of multifocal atrial tachycardia with verapamil. N Engl J Med 312:21

    CAS  PubMed  Google Scholar 

  • Lewalter T, Schrickel J, Shlevkov N, Lüderitz B (2002) Kardiale Effekte von Amiodaron. Dt Ärztebl 30:2040–2046

    Google Scholar 

  • Lewalter T, Tebbenjohanns J, Wichter T (2008) Kommentar zu “ACC/ AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation — executive summary”. Kardiologe 2:181–205

    Google Scholar 

  • Li J, Zhang Q, Zhang M (2007) Intravenous magnesium for acute myocardial infarction. Cochrane Database Syst Rev 18:CD002755

    Google Scholar 

  • Lim PK, Trewby PN, Storey GCA, Holt DW (1984) Neuropathy and fatal hepatitis in a patient receiving amiodarone. Br Med J 288:1638

    CAS  Google Scholar 

  • Lombardi F, Borggrefe M, Ruzyllo W, Lüderitz B (2006) A-COMET II. Azimilide vs placebo and sotalol for persistent atrial fibrillation: the A-COMET-II trial. Eur Heart J 27:2224–2231

    CAS  PubMed  Google Scholar 

  • Lown B (1985) Lidocaine to prevent ventricular fibrillation. M Engl Med 31:1154

    Google Scholar 

  • Lüderitz B (1978) Betarezeptorenblocker bei kardialen Rhythmusstörungen. Internist 19:532

    PubMed  Google Scholar 

  • Lüderitz B (1983) Mehrmaliger Gebrauch von passageren Schrittmachersonden. Dtsch Med Wochenschr 108:1452

    Google Scholar 

  • Lüderitz B (1984) Gibt es eine thyreotoxische Kardiomyopathie? Dtsch Med Wochenschr 109:203

    PubMed  Google Scholar 

  • Lüderitz B (1993) Editorial: ESVEM: noch nicht der Weisheit letzter Schluß. Münch med Wschr 135:521–522

    Google Scholar 

  • Lüderitz B, Manz M (1994) Die Bedeutung von Magnesium in der Intensivmedizin. Z Kardiol 83 (Suppl 6):121–126

    PubMed  Google Scholar 

  • Lüderitz B, Naumann d’Alnoncourt C, Bolte H-D (1972) Zur kardialen Wirkung der Schilddrüsenhormone. — Elektrophysiologische Messungen am Papillarmuskel des Herzens. Klin Wochenschr 50:978

    PubMed  Google Scholar 

  • Lüderitz B, Mletzko R, Jung W, Manz M (1991) Combination of antiarrhythmic drugs. J Cardiovasc Pharmacol 17:S 48

    Google Scholar 

  • Lüderitz B, Jung W, Manz M (1992) Combination drug therapy for cardiac arrhythmias. New Trends Arrhyt VII:459

    Google Scholar 

  • Manning A, Thisse V, Hodeige D, Richard J, Heyndrickx JP, Chatelain P (1995) SR 33589, a new amiodarone-like antiarrhythmic agent: electrophysiological effects in anesthetized dogs. J Cardiovasc Pharmacol 25(2):252–61

    CAS  PubMed  Google Scholar 

  • Manning AS, Bruyninckx C, Ramboux J, Chatelain P (1995) SR 33589, a new amiodarone-like agent: effect on ischemia-and reperfusioninduced arrhythmias in anesthetized rats. J Cardiovasc Pharmacol 26(3):453–61

    CAS  PubMed  Google Scholar 

  • Manz M, Lüderitz B (1985) Herzrhythmusstörungen: Arrhythmieerfassung und-quantifizierung. Inn Med 12:220

    Google Scholar 

  • Manz M, Lüderitz B (1992) Der plötzliche Herztod — Möglichkeiten und Grenzen der medikamentösen Therapie. Z Kardiol 81:237–245

    CAS  PubMed  Google Scholar 

  • Manz M, Lüderitz B (1995) Medikamentöse Therapie von Herzrhythmusstörungen. Bay Int 15:15–21

    Google Scholar 

  • Manz M, Steinbeck G, Lüderitz B (1981) Zur Wirkung von Diltiazem bei supraventrikulären Tachykardien. In: Bender F, Greeff K (Hrsg) Calcium-Antagonisten zur Behandlung der Angina pectoris, Hypertonie und Arrhythmie. Excerpta Medica, Amsterdam

    Google Scholar 

  • Manz M, Kuhl AJ, Lüderitz B (1985) Sotalol bei supraventrikulärer Tachykardie. Elektrophysiologische Messungen bei Wolff-Parkinson-White-Syndrom und AV-Knoten-Reentrytachykardie. Z Kardiol 74:500

    CAS  PubMed  Google Scholar 

  • Manz M, Wagner WL, Lüderitz B (1988) Combination of mexiletine and sotalol in complex ventricular arrhythmias. New Trends Arrhyt III:35 (Suppl)

    Google Scholar 

  • Manz M, Gembruch U, Nitsch J, Hansmann M, Lüderitz B (1990) Amiodarone applied intravascularly for control of refractory ventricular tachycardia in fetus with severe hydrops fetalis. JACC 15:176 A

    Google Scholar 

  • Manz M, Jung W, Mletzko R, Lüderitz B (1990) Hämodynamik bei ventrikulären Tachyarrhythmien und deren Behandlung. In: Lüderitz B (Hrsg) Arrhythmiebehandlung und Hämodynamik. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  • Manz M, Jung W, Lüderitz B (1992) Wer muß zur elektrophysiologischen Studie überwiesen werden? Therapeutische Umschau 49:559–564

    CAS  PubMed  Google Scholar 

  • Manz M, Jung W, Lüderitz B (1994) Der implantierbare Kardioverter/Defibrillator zur Verhinderung des plötzlichen Herztodes. Herzschr Elektrophys 5 (Suppl 1):62–65

    Google Scholar 

  • Marcus FI, Fontaine G (1995) Arrhythmogenic right ventricular dysplasia/cardiomyopathy: A review. PACE 18:1298–1314

    CAS  PubMed  Google Scholar 

  • Marill K A, Wolfram S, Desouza I S (2009) Adenosine for wide-complex tachycardia: efficacy and safety. Crit Care Med 37:2512–2518

    CAS  PubMed  Google Scholar 

  • McGovern K, Geer VR, La Raia PJ, Garan H, Ruskin JN (1984) Possible interaction between Amiodarone and Phenytoin. Ann Intern Med 101:650

    CAS  PubMed  Google Scholar 

  • Mehta AV, Chidambaram B, O’Riordan AC (1992) Verapamil-induced gingival hyperplasia in children. Am Heart J 124:535–536

    CAS  PubMed  Google Scholar 

  • Miwa L, Jolson HM (1992) Propafenone associated agranulocytosis. PACE 15:387–390

    CAS  PubMed  Google Scholar 

  • Mletzko R, Jung W, Manz M, Kamradt T, Vogel F, Lüderitz B (1989) Arrhythmogener Effekt von Flecainid — Therapie mit Magnesium i. v. Z Kardiol 78:602–606

    CAS  PubMed  Google Scholar 

  • Naccarelli GV, Wolbrette DL, Khan M, Bhatta L, Hynes J, Samii S, Luck J (2003) Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials. Am J Cardiol 91(6A):15D–26D

    CAS  PubMed  Google Scholar 

  • Nadamanee K, Feld G, Hendrickson J, Singh PN, Singh BN (1985) Electrophysiologic and antiarrhythmic effects of sotalol in patients with life-threatening ventricular tachyarrhythmias. Circulation 72:555

    Google Scholar 

  • Narimatsu A, Taira N (1976) Effects on atrio-ventricular conduction of calcium-antagonistic coronary vasodilators, local anesthetics and quinidine injected into the posterior and the anterior septal artery of the atrio-ventricular node preparation of the dog. Naunyn-Schmiedebergs Arch Pharmacol 294:169

    CAS  PubMed  Google Scholar 

  • Nathan AW, Hellestrand KJ, Bexton RS, Banim SO, Spurrell RAJ, Camm AJ (1984) Proarrhythmic effects of the new antiarrhythmic agent flecainide acetate. Am Heart J 107:222

    CAS  PubMed  Google Scholar 

  • Naumann d’Alnoncourt C, Cardinal R, Janse MJ (1981) Über die arrhythmogene Wirkung von Potentialdifferenzen im Ventrikelmyokard. In: Lüderitz B (Hrsg) Ventrikuläre Herzrhythmusstörungen. Pathophysiologie — Klinik — Therapie. Springer, Berlin Heidelberg New York

    Google Scholar 

  • Naumann d’Alnoncourt C, Zierhut W, Lüderitz B (1981) Wirkung von Diltiazem auf abnorme Reizbildung in Purkinje-Fasern bei Ischämie. In: Bender F, Greeff K (Hrsg) Calcium-Antagonisten zur Behandlung der Angina pectoris, Hypertonie und Arrhythmie. Excerpta Medica, Amsterdam

    Google Scholar 

  • Nitsch J, Lüderitz B (1984) Kontrolle der antiarrhythmischen Therapie mit Amiodaron. Dtsch Med Wochenschr 109:492

    CAS  PubMed  Google Scholar 

  • Nitsch J, Lüderitz B (1990) Blutspiegelbestimmung und Pharmakodynamik der Antiarrhythmika. In: Lüderitz B (Hrsg) Arrhythmiebehandlung und Hämodynamik. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  • Oetgen WJ, Tibbits PA, Abt MEO, Goldstein RE (1983) Clinical and electrophysiologic assessment of oral flecainide acetate for recurrent ventricular tachycardia: evidence for exacerbation of electrical instability. Am J Cardiol 52:746

    CAS  PubMed  Google Scholar 

  • Ohashi N, Mitamura H, Ogawa S (2009) Development of newer calcium channel antagonists: therapeutic potential of efonidipine in preventing electrical remodeling during atrial fibrillation. Drugs 69: 21–30

    CAS  PubMed  Google Scholar 

  • Ohashi N, Mitamura H, Tanimoto K, et al. (2004) A comparison between calcium channel blocking drugs with different potencies for T-and L-type channels in preventing atrial electrical remodeling. J Cardiovasc Pharmacol 44:386–392

    CAS  PubMed  Google Scholar 

  • Ono H, Himori N, Taira N (1977) Chronotropic effects of coronary vasodilators as assessed in the isolated blood-perfused sinoatrial node preparation of the dog. Tohoku J Exp Med 121:383

    CAS  PubMed  Google Scholar 

  • Packer M et al. for the Carvedilol Heart Failure Group (1996) The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 334:1349–1355

    CAS  PubMed  Google Scholar 

  • Patten M, Maas R, Bauer P et al. (2004) Suppression of paroxysmal atrial tachyarrhythmias-results of the SOPAT trial. Eur Heart J 25:1395–1404

    PubMed  Google Scholar 

  • Pickardt CR (1985) Amiodaron und Schilddrüse. Internistische Welt 12:356

    Google Scholar 

  • Pitt AD, Fernandes C, Bewick NL, Hemsworth PD, Buhagiar KA, Hansen PS, Rasmussen HH, Delbridge L, Whalley DW (2003) Chronic amiodarone-induced inhibition of the Na+-K+ pump in rabbit cardiac myocytes is thyroid-dependent: comparison with dronedarone. Cardiovasc Res 57(1):101–8

    CAS  PubMed  Google Scholar 

  • Podrid PJ, Morganroth J (1985) Aggravation of arrhythmia during drug therapy: experience with flecainide acetate. Practical Cardiol 11:55

    Google Scholar 

  • Prescott LF, Pottage A, Clements JA (1977) Absorption, distribution and elimination of mexiletine. Postgrad Med J 53[Suppl I]:50

    CAS  PubMed  Google Scholar 

  • Riccardi A, Arbosello E, Ghinatti M et al. (2008) Adenosine in the treatment of supraventricular tachycardia: 5 years of experience (2002–2006). Am J Emerg Med 26:879–882

    PubMed  Google Scholar 

  • Pritchett E, Kowey P, Connolley S et al. (2006) Antiarrhythmic efficacy of azimilide in patients with atrial fibrillation. Maintenance of sinus rhythm after cardioversion to sinus rhythm. Am Heart J 151:1043–1049

    CAS  PubMed  Google Scholar 

  • Pritchett E, Page R, Connolley S et al. (2000) Antiarrhythmic effects of azimilide in atrial fibrillation: Efficacy and dose-response. J Am Coll Cardiol 36:794–802

    CAS  PubMed  Google Scholar 

  • Rochetaing A, Barbe C, Kreher P (2001) Beneficial effects of amiodarone and dronedarone (SR 33589b), when applied during low-flow ischemia, on arrhythmia and functional parameters asssessed during reperfusion in isolated rat hearts. J Cardiovasc Pharmacol 38(4):500–11

    CAS  PubMed  Google Scholar 

  • Romano C, Gemme G, Pongiglione R (1956) Aritmie cardiache rare dell’ età pediatrica. Clin Pediatr 45:656

    Google Scholar 

  • Rosen KM, Barwolf C, Ehsani A, Rahimtoola SH (1972) Effects of lidocaine and propranolol on the normal and anomalous pathways in patients with preexcitation. Am J Cardiol 30:801

    CAS  PubMed  Google Scholar 

  • Rossmann EL, Liu K, Morgan GA et al. (2009) The gap junction modifier, GAP 134, improves conduction and reduces atrial fibrillation/flutter in the canine sterile pericarditis model. J Pharmacol Exp Ther 329:1127–1133

    Google Scholar 

  • Roy D, Pratt CM, Torp-Pedersen C et al. (2008) Vernakalant hydrochloride for rapid conversion of atrial fibrillation: a phase 3, randomised, placebo-controlled trial. Circulation 117:1518–1525

    CAS  PubMed  Google Scholar 

  • Schaumlöffel E (1974) Pharmakokinetische Studien mit radioaktiv markiertem N-Propyl-Ajmalinium-Hydrogentartrat an Ratte und Mensch. Med Welt 25:2008–2014

    PubMed  Google Scholar 

  • Scholz H (1976) Disopyramid-Phosphat: Elektrophysiologische und inotrope Wirkungen am Katzenpapillarmuskel im Vergleich mit Chinidin. Arzneimittelforsch 26:469

    CAS  PubMed  Google Scholar 

  • Schrickel J, Schwab JO, Yang A et al. (2006) „Torsade de pointes“ in patients with structural heart disease and atrial fibrillation treated with amidarone, β-blockers and digitalis. PACE 29:1–4

    Google Scholar 

  • Schuff-Werner P, Kaiser D (1980) Cholestatische Hepatitis nach antiarrhythmischer Therapie mit Propafenon. Dtsch Med Wochenschr 105:137

    CAS  PubMed  Google Scholar 

  • Seipel L (1987) Klinische Elektrophysiologie des Herzens. (2. Aufl.) Thieme, Stuttgart

    Google Scholar 

  • Seipel L, Gleichmann U, Loogen F (1973) Die Wirkung von Antiarrhythmika auf die intrakardiale Erregungsleitung im His-Bündelelektrogramm. Verh Dtsch Ges Herz-/Kreislaufforsch 79:993

    CAS  Google Scholar 

  • Senges J, Lengfelder W, Jauernig R, Czygan E, Brachmann. J, Rizos J, Cobbe S, Kübler W (1984) Electrophysiologic testing in assessment of therapy with sotalol for sustained ventricular tachycardia. Circulation 69:577

    CAS  PubMed  Google Scholar 

  • Shamiss Y, Khaykin Y, Oosthuizen R et al. (2009) Dofetilide is safe and effective in preventing atrial fibrillation recurrences in patients accepted for catheter ablation. Europace 11:1448–1455

    PubMed  Google Scholar 

  • Siebenlist D, Nürnberger M, Herrmann G, Gattenlöhner W (1982) Intoxikation mit Propafenon. Intensivmedizin 19:151

    Google Scholar 

  • Sing SN, Tang XC, Reda D, Singh BN (2009) Systematic electrocardioversion for atrial fibrillation and role of antiarrhythmic drugs: a substudy of the SAFE-T trial. Heart Rhythm 6:152–155

    Google Scholar 

  • Singh BN, Connolly SJ, Crijns HJ, Roy D, Kowey PR, Capucci A, Radzik D, Aliot EM, Hohnloser SH (2007) Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter. N Engl J Med 357(10):987–99

    CAS  PubMed  Google Scholar 

  • Singh BN, Singh SN, Reda DJ et al. (2005) Amiodarone versus sotalol for atrial fibrillation. N Engl J Med 352:1861–1872

    CAS  PubMed  Google Scholar 

  • Stäubli M, Bischoff P, Wimpfheimer C, Studer H (1981) Amiodaron und Schilddrüse. Schweiz Med Wochenschr 111:1590

    PubMed  Google Scholar 

  • Stäubli M, Studer H (1981) Behandlung der Arrhythmier mit Amiodaron. Schweiz Med Wochenschr 111:460

    PubMed  Google Scholar 

  • Steinbeck G, Bach P, Haberl R (1986) Electrophysiologic and antiarrhythmic efficacy of oral sotalol for sustained ventricular tachyarrhythmias: Evaluation by programmed stimulation and ambulatory electrocardiogramm. J Am Coll Cardiol 8:949

    CAS  PubMed  Google Scholar 

  • Steinbeck G, Doliwa R, Bach P (1988) Therapie des paroxysmalen Vorhofflimmerns — Herzglykoside allein oder in Kombination mit Antiarrhythmika. Dtsch Med Wochenschr 113:1867–1871

    CAS  PubMed  Google Scholar 

  • Steinbeck G, Andresen D, Bach P, Haberl R, Oeff M, Hoffman E, Leitner ER von (1992) A comparison of electrophysiologically guided antiarrhythmic drug therapy with beta-blocker therapy in patients with symptomatic, sustained ventricular tachyarrhythmias. N Engl J Med 327:987–992

    CAS  PubMed  Google Scholar 

  • Stern H, Scheininger M, Theisen F, Theisen K (1985) Antiarrhythmische Therapie mit Flecainid in Kombination mit und im Vergleich zu Propranolol. Schwerpunkt Medizin 85:46

    Google Scholar 

  • Sun W, Sarma JS, Singh BN (1999) Electrophysiological effects of dronedarone (SR33589), a noniodinated benzofuran derivative, in the rabbit heart: comparison with amiodarone. Circulation 100(22):2276–81

    CAS  PubMed  Google Scholar 

  • Sun W, Sarma JS, Singh BN (2002) Chronic and acute effects of dronedarone on the action potenzial of rabbit atrial muscle preparations: comparison with amiodarone. J Cardiovasc Pharmacol 39(5):677–84

    CAS  PubMed  Google Scholar 

  • Talbot RG, Nimmo J, Julian DG, Clark RA, Neilson JMM, Prescott LF (1973) Treatment of ventricular arrhythmias with mexiletine (Kö 1137). Lancer II:399

    Google Scholar 

  • Tartini R, Kappenberger L, Steinbrunn W (1982) Gefährliche Interaktionen zwischen Amiodaron und Antiarrhythmika der Klasse I. Schweiz Med Wochenschr 112:1585

    CAS  PubMed  Google Scholar 

  • Tebbenjohanns J, Lüderitz B (1995) Adenosin. Internist 36:296–299

    CAS  PubMed  Google Scholar 

  • Thomas D, Kathofer S, Zhang W, Wu K, Wimmer AB, Zitron E, Kreye VA, Katus HA, Schoels W, Karle CA, Kiehn J (2003) Acute effects of dronedarone on both components of the cardiac delayed rectifier K+ current, HERG and KvLQT1/minK potassium channels. Br J Pharmacol 140(5):996–1002

    CAS  PubMed  Google Scholar 

  • Ting S, Lee D, Maclean D, Sheerin N (2008) Paranoid psychosis and myoclonus: Flecainide toxicity in renal failure. Cardiology 111:83–86

    CAS  PubMed  Google Scholar 

  • Touboul P, Brugada J, Capucci A, Crijns HJ, Edvardsson N, Hohnloser SH (2003) Dronedarone for prevention of atrial fibrillation: a doseranging study. Eur Heart J 24(16):1481–7

    CAS  PubMed  Google Scholar 

  • Trujillo TC, Nolan PE (2000) Antiarrhythmic agents: Drug interactions of clinical significance. Drug Saf 23:509–532

    CAS  PubMed  Google Scholar 

  • Twum-Barima Y, Carruthers SG (1981) Quinidine-rifampicine interaction. N Engl J Med 303:1466

    Google Scholar 

  • Valderrama AL, Dunbar SB, Mensah GA (2005) Atrial fibrillation: public health implications. Am J Prev Med 29(5 Suppl 1):75–80

    PubMed  Google Scholar 

  • Valentine PA, Frew JL, Mashford ML, Sloman JG (1974) Lidocaine in the prevention of sudden death in the pre-hospital phase of acute infarction. A double-blind study. N Engl J Med 291:1327

    CAS  PubMed  Google Scholar 

  • Van Gelder IC, Hagens VE, Bosker HA, Kingma JH, Kamp O, Kingma T, Said SA, Darmanata JI, Timmermans AJ, Tijssen JG, Crijns HJ (2002) A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 347(23): 1834–40

    PubMed  Google Scholar 

  • van Opstal JM, Schoenmakers M, Verduyn SC, de Groot SH, Leunissen JD, van Der Hulst FF, Molenschot MM, Wellens HJ, Vos MA (2001) Chronic amiodarone evokes no torsade de pointes arrhythmias despite QT lengthening in an animal model of acquired long-QT syndrome. Circulation 104(22):2722–7

    PubMed  Google Scholar 

  • Varro A, Takacs J, Nemeth M, Hala O, Virag L, Iost N, Balati B, Agoston M, Vereckei A, Pastor G, Delbruyere M, Gautier P, Nisato D, Papp JG (2001) Electrophysiological effects of dronedarone (SR 33589), a noniodinated amiodarone derivative in the canine heart: comparison with amiodarone. Br J Pharmacol 133(5):625–34

    CAS  PubMed  Google Scholar 

  • Vaughan Williams EM (1970) Classification of antiarrhythmic drugs. In: Sandoe E, Flensted-Jensen E, Olsen KH (eds) Cardiac arrhythmias. Astra, Södertälje

    Google Scholar 

  • Vaughan Williams EM (1973) The development of new antidysrhythmic drugs. Schweiz Med Wochenschr 103:262

    CAS  Google Scholar 

  • Verduyn SC, Vos MA, Leunissen HD, van Opstal JM, Wellens HJ (1999) Evaluation of the acute electrophysiologic effects of intravenous dronedarone, an amiodarone-like agent, with special emphasis on ventricular repolarization and acquired torsade de pointes arrhythmias. J Cardiovasc Pharmacol 33(2):212–22

    CAS  PubMed  Google Scholar 

  • Wagner WL, Manz M, Lüderitz B (1987) Combination of sotalol with the type-I-B-agents tocainide or mexiletine in patients with ventricular arrhythmias. Z Kardiol 76:296

    CAS  PubMed  Google Scholar 

  • Wakasa Y, Ikeda T, Oshiro Y, Numa T, Sugimoto T (1979) Beneficial effects of diltiazem on reentrant tachycardia involving A-V conduction. In: Proceedings of the VIth World Symposium on Cardiac Pacing, Montreal 1979

    Google Scholar 

  • Waldo AL, Camm AJ, deRuyter H et al. for the SWORD investigators (1996) Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. Lancet 348:7–12

    CAS  PubMed  Google Scholar 

  • Waleffe A, Bruninx P, Rabine LM, Kulbertus HE (1979) Effects of tocainide studied with programmed electrical stimulation of the heart in patients with re-entrant tachyarrhythmias. Am J Cardiol 43:292

    CAS  PubMed  Google Scholar 

  • Waleffe A, Mary-Rabine L, Legrand V, Demoulin JCI, Kulbertus HE (1980) Combined mexiletine and amiodarone treatment of refractory recurrent ventricular tachycardia. Am Heart J 100:78

    Google Scholar 

  • Ward OCJ (1964) A new familial cardiac syndrome in children. J Irish Med Ass 54:103

    CAS  Google Scholar 

  • Weber R, Letsas KP, Asentz T, Kalusche D (2009) Adenotive sensitive focal atrial tachycardia originating from the non-coronary aortic cusp. Europace 11:823–826

    PubMed  Google Scholar 

  • Wehr M, Küllmer B (1984) Paradoxe Reaktion nach Flecainid. Dtsch Med Wochenschr 109:117

    CAS  PubMed  Google Scholar 

  • Weirich J, Antoni H (1990) Diffential analysis of the frequency-dependent effects of class 1 antiarrhythmic drugs according to periodical ligand binding: Implications for antiarrhythmic and proarrhythmic efficacy. J Cardiovasc Pharrn 15:998–1009

    CAS  Google Scholar 

  • Wichter R, Borggrefe M, Haverkamp W, Chen Y, Breithardt G (1992) Efficacy of antiarrhythmic drugs in patients with arrhythmogenic right ventricular disease. Circulation 86:29–27

    CAS  PubMed  Google Scholar 

  • Wilbur SL, Marchlinski FE (1997) Adenosine as an antiarrhythmic agent. Am J Cardiol 79/12 A:30–37

    Google Scholar 

  • Wit AL, Hoffmann BF, Rosen MR (1975) Electrophysiology and pharmacology of cardiac arrhythmias. IX. Cardiac electrophysiologic effects of beta adrenergie receptor stimulation and blockade. Part C. Am Heart J 90:795

    CAS  Google Scholar 

  • Woods KL, Fletcher S, Roffe CH, Haider Y (1992) Intravenous magnesium sulphate in suspected acute myocardial infarction: result of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2). Lancet 339:1553–1558

    CAS  PubMed  Google Scholar 

  • Woosley RL, Shand DG (1978) Pharmacokinetics of antiarrhythmic drugs. Am J Cardiol 41:986

    CAS  PubMed  Google Scholar 

  • Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB, Kellen JC, Greene HL, Mickel MC, Dalquist JE, Corley SD (2002) A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 347(23):1825–33

    CAS  PubMed  Google Scholar 

  • Yang F, Hanon S, Lam P, Schweitzer P (2009) Quinidine revisited. The American Journal for Medicine 122:317–321

    CAS  Google Scholar 

  • Yeung-Lai-Wah JA, Murdock CJ, Boone J, Kerr CR (1992) Propafenone-Mexiletine combination for the treatment of sustained ventricular tachycardia. J Am Coll Cardiol 20:547–551

    CAS  PubMed  Google Scholar 

  • Zareba KM (2006) Dronedarone: a new antiarrhythmic agent. Drugs Today (Barc) 42(2):75–86

    CAS  Google Scholar 

  • Zekorn C, Achtert G, Hausleiter HJ, Moon Ch, Eichelbaum M (1985) Pharmacokinetics of N-propylajmaline in relation to polymorphic sparteine oxidation. Klin Wochenschr 63:1180

    CAS  PubMed  Google Scholar 

  • Zipes DP, Fisher JC (1974) Effects of agents which inhibit the slow channel on sinus node automaticity and atrioventricular conduction in the dog. Circ Res 34:184

    CAS  PubMed  Google Scholar 

Literatur

  • Antoni H (1972a) Physiologische Grundlagen bei der Erzeugung und Unterbrechung von Vorhof-und Kammerflimmern des Herzens durch elektrischen Strom. Herz/Kreisl 4:342

    Google Scholar 

  • Antoni H (1972b) Physiologische Grundlagen der Elektrostimulation und der Elektrokonversion des Herzens. Intensivmedizin 9:166

    Google Scholar 

  • Kerber RE, Sarnat W (1979) Factors influencing the success of ventricular defibrillation in man. Circulation 60:226

    CAS  PubMed  Google Scholar 

  • Kirchhof P, Eckardt L, Loh P, et al. (2002) Anterior-posterior versus anteriorlateral electrode positions for external cardioversion of atrial fibrillation: a randomissed trial. Lancet 360:1275–1279

    PubMed  Google Scholar 

  • Lown B, Amarasingham R, Neumann J (1962) New method for terminating cardiac arrythmias. Use of synchronized capacitor discharge. JAMA 182:548

    CAS  PubMed  Google Scholar 

  • Lüderitz B (1993) Therapie der Herzrhythmusstörungen, 4. Aufl. Springer, Berlin Heidelberg New York Tokio

    Google Scholar 

  • Morani G, Cicoria M, Pozzani L, et al. (2009) Outpatient electrical cardioversion of atrial fibrillation: 8 years’ experience. Analysis of shockrelated arrhythmias. Pacing Clin Electrophysiol 32:1152–1158

    PubMed  Google Scholar 

  • Reifel J A (2009) Cardioversion for atrial fibrillation: treatment options and advances. Pacing Clin Electrophysiol 32:1073–1084

    Google Scholar 

Literatur

  • Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, Kocovic DZ, Packer M, Clavell AL, Hayes DL, Ellestad M, Trupp RJ, Underwood J, Pickering F, Truex C, McAtee P, Messenger J (2002) Cardiac resynchronization in chronic heart failure. N Engl J Med 346:1845–53

    PubMed  Google Scholar 

  • Aggarwal RK, Connelly DT, Ray SG, Ball J, Charles RG (1995) Early complications of permanent pacemaker implantation: no difference between dual and single chamber systems. Br Heart J 73:571–5

    CAS  PubMed  Google Scholar 

  • Andersen HR, Nielsen JC, Thomsen PE, Thuesen L, Mortensen PT, Vesterlund T, Pedersen AK (1997) Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome. Lancet 350:1210–6

    CAS  PubMed  Google Scholar 

  • Andersen HR, Thuesen L, Bagger JP, Vesterlund T, Thomsen PE (1994) Prospective randomised trial of atrial versus ventricular pacing in sick-sinus syndrome. Lancet 344:1523–8

    CAS  PubMed  Google Scholar 

  • Auricchio A, Stellbrink C, Butter C, Sack S, Vogt J, Misier AR, Bocker D, Block M, Kirkels JH, Kramer A, Huvelle E (2003) Clinical efficacy of cardiac resynchronization therapy using left ventricular pacing in heart failure patients stratified by severity of ventricular conduction delay. J Am Coll Cardiol 42:2109–16

    PubMed  Google Scholar 

  • Auricchio A, Stellbrink C, Sack S, Block M, Vogt J, Bakker P, Huth C, Schondube F, Wolfhard U, Bocker D, Krahnefeld O, Kirkels H (2002) Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol 39:2026–33

    PubMed  Google Scholar 

  • Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH (2005) Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352:225–37

    CAS  PubMed  Google Scholar 

  • Brignole M, Alboni P, Benditt DG, Bergfeldt L, Blanc JJ, Bloch Thomsen PE, Gert van Dijk J, Fitzpatrick A, Hohnloser S, Janousek J, Kapoor W, Anne Kenny R, Kulakowski P, Masotti G, Moya A, Raviele A, Sutton R, Theodorakis G, Ungar A, Wieling W (2005) [Guidelines on management (diagnosis and treatment) of syncope. Update 2004. Executive summary]. Rev Esp Cardiol 58:175–93

    PubMed  Google Scholar 

  • Brignole M, Menozzi C, Moya A, Garcia-Civera R, Mont L, Alvarez M, Errazquin F, Beiras J, Bottoni N, Donateo P (2001) Mechanism of syncope in patients with bundle branch block and negative electrophysiological test. Circulation 104:2045–50

    CAS  PubMed  Google Scholar 

  • Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, DeMets D, White BG, DeVries DW, Feldman AM (2004) Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350:2140–50

    CAS  PubMed  Google Scholar 

  • Camm AJ, Sulke N, Edvardsson N, Ritter P, Albers BA, Ruiter JH, Lewalter T, Capucci PA, Hoffmann E; AFTherapy Investigators (2007) Conventional and dedicated atrial overdrive pacing for the prevention of paroxysmal atrial fibrillation: the AFTherapy study. Europace 9:1110–18

    CAS  PubMed  Google Scholar 

  • Cazeau S, Leclercq C, Lavergne T, Walker S, Varma C, Linde C, Garrigue S, Kappenberger L, Haywood GA, Santini M, Bailleul C, Daubert JC (2001) Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 344:873–80

    CAS  PubMed  Google Scholar 

  • Charles R, Holt S, Kay JM, Epstein EJ, Rees JR (1981) Myocardial ultrastructure and the development of atrioventricular block in Kearns-Sayre syndrome. Circulation 63:214–9

    CAS  PubMed  Google Scholar 

  • Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L (2005) The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352:1539–49

    CAS  PubMed  Google Scholar 

  • Col JJ, Weinberg SL (1972) The incidence and mortality of intraventricular conduction defects in acute myocardial infarction. Am J Cardiol 29:344–50

    CAS  PubMed  Google Scholar 

  • Connolly SJ, Kerr CR, Gent M, Roberts RS, Yusuf S, Gillis AM, Sami MH, Talajic M, Tang AS, Klein GJ, Lau C, Newman DM (2000) Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. Canadian Trial of Physiologic Pacing Investigators. N Engl J Med 342:1385–91

    CAS  PubMed  Google Scholar 

  • Dhingra RC, Denes P, Wu D, Chuquimia R, Rosen KM (1974) The significance of second degree atrioventricular block and bundle branch block. Observations regarding site and type of block. Circulation 49:638–46

    CAS  PubMed  Google Scholar 

  • Dhingra RC, Wyndham C, Bauernfeind R, Swiryn S, Deedwania PC, Smith T, Denes P, Rosen KM (1979) Significance of block distal to the His bundle induced by atrial pacing in patients with chronic bifascicular block. Circulation 60:1455–64

    CAS  PubMed  Google Scholar 

  • Higgins SL, Hummel JD, Niazi IK, Giudici MC, Worley SJ, Saxon LA, Boehmer JP, Higginbotham MB, De Marco T, Foster E, Yong PG (2003) Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. J Am Coll Cardiol 42:1454–9

    PubMed  Google Scholar 

  • Hoffmann E, Sulke N, Edvardsson N, Ruiter J, Lewalter T, Capucci A, Schuchert A, Janko S, Camm J; Atrial Fibrillation Therapy Trial Investigators (2006) New insights into the initiation of atrial fibrillation: a detailed intraindividual and interindividual analysis of the spontaneous onset of atrial fibrillation using new diagnostic pacemaker features. Circulation 113:1933–41

    PubMed  Google Scholar 

  • Irnich W, Balz L (1992) Jahresbericht 1992 des Zentralregisters Herzschrittmacher. Herzschrittmacher 6:115

    Google Scholar 

  • Kerr CR, Connolly SJ, Abdollah H, Roberts RS, Gent M, Yusuf S, Gillis AM, Tang AS, Talajic M, Klein GJ, Newman DM (2004) Canadian Trial of Physiological Pacing: Effects of physiological pacing during longterm follow-up. Circulation 109:357–62

    PubMed  Google Scholar 

  • Lamas GA, Lee KL, Sweeney MO, Silverman R, Leon A, Yee R, Marinchak RA, Flaker G, Schron E, Orav EJ, Hellkamp AS, Greer S, McAnulty J, Ellenbogen K, Ehlert F, Freedman RA, Estes NA, 3rd, Greenspon A, Goldman L (2002) Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. N Engl J Med 346:1854–62

    PubMed  Google Scholar 

  • Lamas GA, Orav EJ, Stambler BS, Ellenbogen KA, Sgarbossa EB, Huang SK, Marinchak RA, Estes NA, 3rd, Mitchell GF, Lieberman EH, Mangione CM, Goldman L (1998) Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual-chamber pacing. Pacemaker Selection in the Elderly Investigators. N Engl J Med 338:1097–104

    CAS  PubMed  Google Scholar 

  • Lauck G, von Smekal A, Wolke S, Seelos KC, Jung W, Manz M, Luderitz B (1995) Effects of nuclear magnetic resonance imaging on cardiac pacemakers. Pacing Clin Electrophysiol 18:1549–1555

    CAS  PubMed  Google Scholar 

  • Lemke B, Fischer W, Schulten KH (1996) Richtlinien zur Herzschrittmachertherapie: Indikationen, Systemwahl, Nachsorge. Z Kardiol 85:611–628

    Google Scholar 

  • Lemke B, Nowak B, Pfeiffer D (2005) Guidelines for heart pacemaker therapy. Z Kardiol 94:704–20

    CAS  PubMed  Google Scholar 

  • Lewalter T, Yang A, Pfeiffer D, Ruiter J, Schnitzler G, Markert T, Asklund M, Przibille O, Welz A, Esmailzadeh B, Linhart M, Lüderitz B (2006) Individualized selection of pacing algorithms for the prevention of recurrent atrial fibrillation: Results from the VIP registry. Pacing Clin Electrophysiol 29:124–34 Martinelli M, Costa R, Nishioka S, Pedrosa A, Siqueira S, Crevelari E, Scanavacca M, d’Avila A, Sosa E (2002) Criteria for pacemaker explant in patients without a precise indication for pacemaker implantation. Pacing Clin Electrophysiol 25:272–7

    PubMed  Google Scholar 

  • McAnulty JH, Rahimtoola SH, Murphy E, DeMots H, Ritzmann L, Kanarek PE, Kauffman S (1982) Natural history of “high-risk” bundlebranch block: final report of a prospective study. N Engl J Med 307:137–43

    CAS  PubMed  Google Scholar 

  • Michaelsson M, Jonzon A, Riesenfeld T (1995) Isolated congenital complete atrioventricular block in adult life. A prospective study. Circulation 92:442–9

    CAS  Google Scholar 

  • Moak JP, Barron KS, Hougen TJ, Wiles HB, Balaji S, Sreeram N, Cohen MH, Nordenberg A, Van Hare GF, Friedman RA, Perez M, Cecchin F, Schneider DS, Nehgme RA, Buyon JP (2001) Congenital heart block: development of late-onset cardiomyopathy, a previously underappreciated sequela. J Am Coll Cardiol 37:238–42

    CAS  PubMed  Google Scholar 

  • Nauman d’Alnoncourt C (1983) Bradykarde Rhythmusstörungen. In: Lüderitz B (Hrsg) Herzrhythmusstörungen. Handbuch der Inneren Medizin IX/1. Springer, Berlin Heidelberg New York

    Google Scholar 

  • Perloff JK, Stevenson WG, Roberts NK, Cabeen W, Weiss J (1984) Cardiac involvement in myotonic muscular dystrophy (Steinert’s disease): a prospective study of 25 patients. Am J Cardiol 54:1074–81

    CAS  PubMed  Google Scholar 

  • Phibbs B, Marriott HJ (1985) Complications of permanent transvenous pacing. N Engl J Med 312:1428–1432

    CAS  PubMed  Google Scholar 

  • Pinsky WW, Gillette PC, Garson A, Jr., McNamara DG (1982) Diagnosis, management, and long-term results of patients with congenital complete atrioventricular block. Pediatrics 69:728–33

    CAS  PubMed  Google Scholar 

  • Ritter WS, Atkins JM, Blomqvist CG, Mullins CB (1976) Permanent pacing in patients with transient trifascicular block during acute myocardial infarction. Am J Cardiol 38:205–8

    CAS  PubMed  Google Scholar 

  • Rosenqvist M, Brandt J, Schuller H (1988) Long-term pacing in sinus node disease: effects of stimulation mode on cardiovascular morbidity and mortality. Am Heart J 116:16–22

    CAS  PubMed  Google Scholar 

  • Scheinman MM, Peters RW, Suave MJ, Desai J, Abbott JA, Cogan J, Wohl B, Williams K (1982) Value of the H-Q interval in patients with bundle branch block and the role of prophylactic permanent pacing. Am J Cardiol 50:1316–22

    CAS  PubMed  Google Scholar 

  • Seidl K, Schuchert A, Tebbenjohanns J, Hartung W (2005) Commentary on the guidelines the diagnosis and the therapy of syncope — the European Society of Cardiology 2001 and the update 2004. Z Kardiol 94:592–612

    CAS  PubMed  Google Scholar 

  • Stevenson WG, Perloff JK, Weiss JN, Anderson TL (1990) Facioscapulohumeral muscular dystrophy: evidence for selective, genetic electrophysiologic cardiac involvement. J Am Coll Cardiol 15:292–9

    CAS  PubMed  Google Scholar 

  • Strasberg B, Amat YLF, Dhingra RC, Palileo E, Swiryn S, Bauernfeind R, Wyndham C, Rosen KM (1981) Natural history of chronic seconddegree atrioventricular nodal block. Circulation 63:1043–9

    CAS  PubMed  Google Scholar 

  • Sweeney MO, Hellkamp AS, Ellenbogen KA, Greenspon AJ, Freedman RA, Lee KL, Lamas GA (2003) Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation 107:2932–7

    PubMed  Google Scholar 

  • Tang AS, Roberts RS, Kerr C, Gillis AM, Green MS, Talajic M, Yusuf S, Abdollah H, Gent M, Connolly SJ (2001) Relationship between pacemaker dependency and the effect of pacing mode on cardiovascular outcomes. Circulation 103:3081–5

    CAS  PubMed  Google Scholar 

  • Trappe HJ (1996) Could C-and D-network mobile phones endanger patients with cardiac pacemakers?. Dtsch Med Wochenschr 121: 645

    CAS  PubMed  Google Scholar 

  • Wiegand UK, Schier H, Bode F, Brandes A, Potratz J (1998) Should unipolar leads be implanted in the atrium? A Holter electrocardiographic comparison of threshold adapted unipolar and high sensitive bipolar sensing. Pacing Clin Electrophysiol 21:1601–8

    CAS  PubMed  Google Scholar 

  • Wiegand UK (2008) Avoidance of ventricular pacing in patients with sinus node disease or intermittent AV block. Herzschrittmacherther Elektrophysiol 19:3–10

    CAS  PubMed  Google Scholar 

  • Yang A, Ruiter J, Pfeiffer D, Esmailzadeh B, Welz A, Hochhäusler M, Nickenig G, Lüderitz B, Lewalter T (2006) Identification of “substrate fibrillators” and “trigger fibrillators” by pacemaker diagnostics. Heart Rhythm 3:682–8

    PubMed  Google Scholar 

Literatur

  • Albert CM, Rosenthal L, Calkins H, et al. (2007) Driving and implantable cardioverter-defibrillator shocks for ventricular arrhythmias: results form the TOVA study. J Am Coll Cardiol 50:2233–2240

    PubMed  Google Scholar 

  • Almendral J, Arenal A, Villacastin JP, et al. (1993) The importance of antitachycardia pacing for patients presenting with ventricular tachycardia. Pacing Clin Electrophysiol 16:535–9

    CAS  PubMed  Google Scholar 

  • The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. (1997) A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 337:1576–83

    Google Scholar 

  • Alter P, Waldhans S, Plachta E, et al. (2005) Complications of implantable cardioverter defibrillator therapy in 440 consecutive patients. Pacing Clin Electrophysiol 28:926–32

    PubMed  Google Scholar 

  • Bansch D, Steffgen F, Gronefeld G, et al. (2004) The 1+1 trial: a prospective trial of a dual-versus a single-chamber implantable defibrillator in patients with slow ventricular tachycardias. Circulation 110:1022–9

    PubMed  Google Scholar 

  • Bänsch D, Castrucci M, Bocker D, et al. (2000) Ventricular tachycardias above the initially programmed tachycardia detection interval in patients with implantable cardioverter-defibrillators: incidence, prediction and significance. J Am Coll Cardiol 36:557–65

    PubMed  Google Scholar 

  • Bänsch D, Antz M, Boczor S, et al. (2002) Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the Cardiomyopathy Trial (CAT) Circulation 105:1453–8

    PubMed  Google Scholar 

  • Bardy GH, Lee KL, Mark DB, et al. (2005) Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352:225–37

    CAS  PubMed  Google Scholar 

  • Bigger JT, Jr (1997) Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronaryartery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators. N Engl J Med 337:1569–75

    PubMed  Google Scholar 

  • Block M, Hammel D, Borggrefe M et al. (1991) Initial clinical experiences with a transvenous-subcutaneous defibrillation system. Z Kardiol 80:657–64

    CAS  PubMed  Google Scholar 

  • Bristow MR, Saxon LA, Boehmer J, et al. (2004) Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350:2140–50

    CAS  PubMed  Google Scholar 

  • Brunn J, Bocker D, Weber M, et al. (2000) Is there a need for routine testing of ICD defibrillation capacity? Results from more than 1000 studies. Eur Heart J 21:162–9

    CAS  PubMed  Google Scholar 

  • Buxton AE, Fisher JD, Josephson ME, et al. (1993) Prevention of sudden death in patients with coronary artery disease: the Multicenter Unsustained Tachycardia Trial (MUSTT) Prog Cardiovasc Dis 36:215–26

    CAS  PubMed  Google Scholar 

  • Buxton AE, Lee KL, Fisher JD, et al. (1999) A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter unsustained tachycardia trial investigators. N Engl J Med 341:1882–1890

    CAS  PubMed  Google Scholar 

  • Chambers ST (2005) Diagnosis and management of staphylococcal infections of pacemakers and cardiac defibrillators. Intern Med J 35 Suppl 2:S63–71

    Google Scholar 

  • Connolly SJ, Gent M, Roberts RS, et al. (2000) Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 101: 1297–302

    CAS  PubMed  Google Scholar 

  • Dorian P, Philippon F, Thibault B, et al. (2004) Randomized controlled study of detection enhancements versus rate-only detection to prevent inappropriate therapy in a dual-chamber implantable cardioverter-defibrillator. Heart Rhythm 1:540–7

    PubMed  Google Scholar 

  • Duru F, Luechinger R, Scharf C, et al. (2005) Automatic impedance monitoring and patient alert feature in implantable cardioverter defibrillators: being alert for the unexpected! J Cardiovasc Electrophysiol 16:444–8

    PubMed  Google Scholar 

  • Friedman PA, McClelland RL, Bamlet WR, et al. (2006) Dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: the detect supraventricular tachycardia study. Circulation 113:2871–9

    PubMed  Google Scholar 

  • Fromer M, Brachmann J, Block M, et al. (1992) Efficacy of automatic multimodal device therapy for ventricular tachyarrhythmias as delivered by a new implantable pacing cardioverter-defibrillator. Results of a European multicenter study of 102 implants. Circulation vn86:363–74

    Google Scholar 

  • Hauser RG, Cannom D, Hayes DL, et al. (2002) Long-term structural failure of coaxial polyurethane implantable cardioverter defibrillator leads. Pacing Clin Electrophysiol 25:879–82

    PubMed  Google Scholar 

  • Hauser RG, Hayes DL, Epstein AE, et al. (2006): Multicenter experience with failed and recalled implantable cardioverter-defibrillator pulse generators. Heart Rhythm 3:640–4

    PubMed  Google Scholar 

  • Hohnloser SH, Kuck KH, Dorian P, et al. (2004) Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med 351:2481–8

    CAS  PubMed  Google Scholar 

  • Hurwitz JL, Hook BG, Flores BT, et al. (1993) Importance of abortive shock capability with electrogram storage in cardioverter-defibrillator devices. J Am Coll Cardiol 21:895–900

    CAS  PubMed  Google Scholar 

  • Jimenez-Candil J, Arenal A, Garcia-Alberola A, et al. (2005) Fast ventricular tachycardias in patients with implantable cardioverter-defibrillators: efficacy and safety of antitachycardia pacing. A prospective and randomized study. J Am Coll Cardiol 45: 460–1

    PubMed  Google Scholar 

  • Jung W, Manz M, Moosdorf R, et al. (1994) Clinical efficacy of shock waveforms and lead configurations for defibrillation. Am Heart J 127:985–93

    CAS  PubMed  Google Scholar 

  • Jung W, Lüderitz B (1996) European policy on driving for patients with implantable cardioverter defibrillators. Pacing Clin Electrophysiol 19:981–4

    CAS  PubMed  Google Scholar 

  • Jung W, Andresen D, Block M et al. (2006) Leitlinien zur Implantation von Defibrillatoren. Clin Res Cardiol 95:696–708

    CAS  PubMed  Google Scholar 

  • Kadish A, Dyer A, Daubert JP, et al. (2004) Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 350:2151–8

    CAS  PubMed  Google Scholar 

  • Knuefermann P, Wolpert C, Spehl S, et al. (2000) Implantable cardioverter/defibrillator: long-term stability of the defibrillation threshold with a unipolar electrode configuration (active-can≪) Z Kardiol 89:774–80

    CAS  PubMed  Google Scholar 

  • Kuck KH, Cappato R, Siebels J, et al. (2000) Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH) Circulation 102:748–54

    CAS  PubMed  Google Scholar 

  • Lüderitz B, Jung W, Deister A, et al. (1993) Patient acceptance of the implantable cardioverter defibrillator in ventricular tachyarrhythmias. Pacing Clin Electrophysiol 16:1815–21

    PubMed  Google Scholar 

  • Mirowski M, Reid PR, Mower MM et al. (1980) Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N Engl J Med. 303:322–4

    CAS  PubMed  Google Scholar 

  • Moss AJ, Hall WJ, Cannom DS, et al. (1996) Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 335:1933–40

    CAS  PubMed  Google Scholar 

  • Moss AJ, Zareba W, Hall WJ, et al. (2002) Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346:877–83

    PubMed  Google Scholar 

  • Pacifico A, Wheelan KR, Nasir N, Jr., et al. (1997) Long-term follow-up of cardioverter-defibrillator implanted under conscious sedation in prepectoral subfascial position. Circulation 95:946–50

    CAS  PubMed  Google Scholar 

  • Priori SG, Aliot E, Blomstrom-Lundqvist C, et al. (2001) Task Force on Sudden Cardiac Death of the European Society of Cardiology. Eur Heart J 22:1374–450

    CAS  PubMed  Google Scholar 

  • Sadoul N, Mletzko R, Anselme F, et al. (2005) Incidence and clinical relevance of slow ventricular tachycardia in implantable cardioverter-defibrillator recipients: an international multicenter prospective study. Circulation 112:946–53

    PubMed  Google Scholar 

  • Schaumann A, von zur Muhlen F, Herse B, et al. (1998) Empirical versus tested antitachycardia pacing in implantable cardioverter defibrillators: a prospective study including 200 patients. Circulation 97:66–74

    CAS  PubMed  Google Scholar 

  • Schoenfed MH, Compton SJ, Mead RH, et al. (2004) Remote monitoring of implantable cardioverter defibrillators: a prospective analysis. Pacing Clin Electrophysiol 27:757–763

    Google Scholar 

  • Sweeney MO, Wathen MS, Volosin K, et al. (2006) Appropriate and inappropriate ventricular therapies, quality of life, and mortality among primary and secondary prevention implantable cardioverter defibrillator patients: results from the Pacing Fast VT REduces Shock ThErapies (PainFREE Rx II) trial. Circulation 111:2898–905

    Google Scholar 

  • Strickberger SA, Hummel JD, Bartlett TG, et al. (2003) Amiodarone versus implantable cardioverter-defibrillator:randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia—AMIOVIRT. J Am Coll Cardiol 41:1707–12

    PubMed  Google Scholar 

  • Trappe HJ, Wenzlaff P, Grellman G (1998) Should patients with implantable cardioverter-defibrillators be allowed to drive? Observations in 291 patients from a single center over an 11-year period. J Interv Card Electrophysiol 2:193–201

    CAS  PubMed  Google Scholar 

  • Vijgen J, Botto G, Camm J et al. (2009) Consensus statement of the European Heart Rhythm Association: updated recommendations for driving by patients with implantable cardioverter defibrillators. Europace 11:1097–1107

    PubMed  Google Scholar 

  • Wathen MS, DeGroot PJ, Sweeney MO, et al. (2004) Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results. Circulation 110:2591–6

    PubMed  Google Scholar 

  • Winter J, Zimmermann N, Lidolt H, et al. (2000) Optimal method to achieve consistently low defibrillation energy requirements. Am J Cardiol 86:71K–75K

    CAS  PubMed  Google Scholar 

  • Zipes DP, Camm AJ, Borggrefe M et al. (2006) ACC/AHA/ESC Guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Circulation 114:e385–484

    PubMed  Google Scholar 

Literatur

  • Borggrefe M, Budde T, Podczeck A, Breithardt G (1987) High frequency alternating current ablation of an accessory pathway in humans. J Am Coll Cardiol 10:576–582

    CAS  PubMed  Google Scholar 

  • Calkins H, Yong P, Miller JM et al. (1999) Catheter ablation of accessory pathways, atrioventricular nodal reentrant tachycardia, and the atrioventricular junction. Final results of a prospective, multicenter clinical trial. Circulation 99:262–270

    CAS  PubMed  Google Scholar 

  • Erkapic D, Pitschner H (2008) Komplikationen nach Ablation supraventrikulärer Tachykardien. Herzschr Elektrophys 19:79–83

    Google Scholar 

  • Evans GT, Scheinman MM, Zipes DP et al. (1988) The precutaneous cardiac mapping and ablation registry: final summary of results. PACE 11:1621–1626

    PubMed  Google Scholar 

  • Evans GT, Scheinman MM, Bardy G, et al. (1991) Predictors of inhospital mortality after DC-catheter ablation of the atrioventricular junction. Results of a prospective, international, multicenter study. Circulation 84:1924–37

    PubMed  Google Scholar 

  • Gallagher JJ, Svenson RH, Kasell JH, German LD, Bardy GH, Broughton A, Critelli G (1982) Catheter technique for closed-chest ablation of the atrioventricular conduction system: A therapeutic alternative for the treatment of refractory supraventricular tachycardia. N Engl J Med 306:194–200

    CAS  PubMed  Google Scholar 

  • Hindricks G (1993) The Multicenter European Radiofrequency Survey (MERFS): Complications of radiofrequency catheter ablation of arrhythmias. Eur Heart J 14:1644–1653

    CAS  PubMed  Google Scholar 

  • Hoffmann E, Steinbeck G (1996) Katheterablation supraventrikulärer Tachykardien. Springer Berlin Heidelberg New York

    Google Scholar 

  • Khairy P, Dubuc M (2008) Transcatheter cryoablation part I: Preclinical Experience. PACE 31:112–120

    PubMed  Google Scholar 

  • Manz M, Steinbeck G, Lüderitz B (1983) His-Bündel-Ablation: Eine neue Methode zur Therapie bedrohlicher supraventrikulärer Herzrhythmusstörungen. Internist 24:95

    CAS  PubMed  Google Scholar 

  • Manz M, Kuhl AJ, Lüderitz B (1985) Sotalol bei supraventrikulärer Tachykardie. Elektrophysiologische Messungen bei Wolff-Parkinson-White-Syndrom und AV-Knoten-Reentrytachykardie. Z Kardiol 74:500

    CAS  PubMed  Google Scholar 

  • Manz M, Steinbeck G, Gerckens U, Lüderitz B (1985) Supraventrikuläre Tachykardie: Ergebnisse der His-Bündel-Ablation. Dtsch Med Wochenschr 110:576

    CAS  PubMed  Google Scholar 

  • Scheinman MM (1995) NASPE Policy Statement. NASPE Survey on catheter ablation. PACE 18:1474–1478

    CAS  PubMed  Google Scholar 

  • Scheinman MM, Morady F, Hess D, Gonzales R (1982) Transvenous catheter technique for induction of damage to the atrioventricular junction in man. Am J Cardiol 49:1013

    Google Scholar 

Literatur

  • Collins JJ (1980) Surgery for intractable ventricular arrhythmias. N Engl J Med 303:627

    Google Scholar 

  • Cox JL, Chuessler RB, D’Agostino jr J, Stone CM, Chang BC, Cain ME, Corr PB, Bioneau JP (1991) The surgical treatment of atrial fibrillation. J Thorac Cardiovasc Surg 101:569–583

    CAS  PubMed  Google Scholar 

  • Guiraudon G, Fontaine G, Frank R, Escande G, Etievent P, Cabrol C (1978) Encircling endocardial ventriculotomy: a new surgical treatment for life threatening ventricular tachycardias resistant to medical treatment following myocardial infarction. Ann Thorac Surg 26:438

    CAS  PubMed  Google Scholar 

  • Knaut M (2007) Geschichte der Rhythmuschirurgie mit Fokus auf die chirurgischen Ablationsverfahren zur Behandlung des Vorhofflimmerns. Herzschr Elektrophys 18:54–61

    Google Scholar 

  • Lehmann MH, Saksena S (1991) Implantable cardioverter/defibrillators in cardiovascular practice. Report of the policy conference of the North American Society of Pacing and Electrophysiology. PACE 14:969–979

    CAS  PubMed  Google Scholar 

  • Leitch JW, Gillis AM, Wyse DG et al. (1991) Reduction in defibrillator shocks with an implantable device combining antitachycardia pacing and shock therapy. J Am Coll Cardiol 18:145–151

    CAS  PubMed  Google Scholar 

  • Nath S, Haines DE, Hobson CE, Kron IL, DiMarco JO (1992) Ventricular tachycardia surgery. Cardiovasc Electrophysiol 3:160–172

    Google Scholar 

  • Seipel L, Ostermeyer J, Breithardt G (1983) Operative Therapie von Herzrhythmusstörungen. In Lüderitz B (Hrsg) Herzrhythmusstörungen. Handbuch der Inneren Medizin IX/1. Springer, Berlin Heidelberg New York

    Google Scholar 

Literatur

  • Anghel TM, Pogwizd SM (2007) Creating a cardiac pacemaker by gene therapy. Med Biol Eng Comput 45:145–55

    PubMed  Google Scholar 

  • Cho HC, Kashiwakura Y, Marban E (2007) Creation of a biological pacemaker by cell fusion. Circ Res 100:1112–5

    CAS  PubMed  Google Scholar 

  • de Boer TP, van Veen TA, Houtman MJ, Jansen JA, van Amersfoorth SC, Doevendans PA, Vos MA, van der Heyden MA (2006) Inhibition of cardiomyocyte automaticity by electrotonic application of inward rectifier current from Kir2.1 expressing cells. Med Biol Eng Comput 44:537–42

    PubMed  Google Scholar 

  • Edelberg JM, Aird WC, Rosenberg RD (1998) Enhancement of murine cardiac chronotropy by the molecular transfer of the human beta2 adrenergic receptor cDNA. J Clin Invest 101:337–43

    CAS  PubMed  Google Scholar 

  • Joyner RW, Wilders R, Wagner MB (2007) Propagation of pacemaker activity. Med Biol Eng Comput 45:177–87

    PubMed  Google Scholar 

  • Kashiwakura Y, Cho HC, Barth AS, Azene E, Marban E (2006) Gene transfer of a synthetic pacemaker channel into the heart: a novel strategy for biological pacing. Circulation 114:1682–6

    PubMed  Google Scholar 

  • Marban E, Cho HC (2007) Creation of a biological pacemaker by gene-or cell-based approaches. Med Biol Eng Comput 45:133–44

    PubMed  Google Scholar 

  • Miake J, Marban E, Nuss HB (2003) Functional role of inward rectifier current in heart probed by Kir2.1 overexpression and dominantnegative suppression. J Clin Invest 111:1529–36

    CAS  PubMed  Google Scholar 

  • Noble D, Denyer JC, Brown HF, DiFrancesco D (1992) Reciprocal role of the inward currents ib, Na and i(f) in controlling and stabilizing pacemaker frequency of rabbit sino-atrial node cells. Proc Biol Sci 250:199–207

    CAS  PubMed  Google Scholar 

  • Opthof T (2007) Embryological development of pacemaker hierarchy and membrane currents related to the function of the adult sinus node: implications for autonomic modulation of biopacemakers. Med Biol Eng Comput 45:119–32

    PubMed  Google Scholar 

  • Plotnikov AN, Shlapakova I, Szabolcs MJ, Danilo P, Jr., Lorell BH, Potapova IA, Lu Z, Rosen AB, Mathias RT, Brink PR, Robinson RB, Cohen IS, Rosen MR (2007) Xenografted adult human mesenchymal stem cells provide a platform for sustained biological pacemaker function in canine heart. Circulation 116:706–13

    PubMed  Google Scholar 

  • Potapova I, Plotnikov A, Lu Z, Danilo P, Jr., Valiunas V, Qu J, Doronin S, Zuckerman J, Shlapakova IN, Gao J, Pan Z, Herron AJ, Robinson RB, Brink PR, Rosen MR, Cohen IS (2004) Human mesenchymal stem cells as a gene delivery system to create cardiac pacemakers. Circ Res 94:952–9

    CAS  PubMed  Google Scholar 

  • Roell W, Lewalter T, Sasse P, Tallini YN, Choi BR, Breitbach M, Doran R, Becher UM, Hwang SM, Bostani T, von Maltzahn J, Hofmann A, Reining S, Eiberger B, Gabris B, Pfeifer A, Welz A, Willecke K, Salama G, Schrickel JW, Kotlikoff MI, Fleischmann BK (2007) Engraftment of connexin 43-expressing cells prevents post-infarct arrhythmia. Nature 450:819–24

    CAS  PubMed  Google Scholar 

  • Rosen MR (2007) Biological pacemaking: a concept whose time has come or is coming. Heart 93:145–6

    PubMed  Google Scholar 

  • Rosen MR, Brink PR, Cohen IS, Robinson RB (2004a) Genes, stem cells and biological pacemakers. Cardiovasc Res 64:12–23

    CAS  PubMed  Google Scholar 

  • Rosen MR, Robinson RB, Brink P, Cohen IS (2004b) Recreating the biological pacemaker. Anat Rec A Discov Mol Cell Evol Biol 280:1046–52

    PubMed  Google Scholar 

  • Rosen MR, Brink PR, Cohen IS, Robinson RB (2007) Biological pacemakers based on I(f ). Med Biol Eng Comput 45:157–66

    PubMed  Google Scholar 

  • Wilders R (2007) Computer modelling of the sinoatrial node. Med Biol Eng Comput 45:189–207

    PubMed  Google Scholar 

  • Xue T, Cho HC, Akar FG, Tsang SY, Jones SP, Marban E, Tomaselli GF, Li RA (2005) Functional integration of electrically active cardiac derivatives from genetically engineered human embryonic stem cells with quiescent recipient ventricular cardiomyocytes: insights into the development of cell-based pacemakers. Circulation 111:11–20

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medizinischen Klinik Rheinisches Herz-, Gefäß- und Arrhythmie Zentrum Bonn St. Marienhospital Bonn, Akademisches Lehrkrankenhaus der Universität Bonn, Robert Koch Str. 1, 53115, Bonn

    Prof. Dr. med. Th. Lewalter (Chefarzt)

  2. Medizinischen Klinik und Poliklinik II, Universitätsklinikum Bonn, Sigmund-Freud-Str. 25, 53105, Bonn

    Prof. Dr. med. Dr. h.c. Berndt Lüderitz (Direktor) & Dr. med. J. Schrickel

  3. Klinikum Ludwigsburg Klinik für Innere Medizin, Kardiologie Nephrologie und internistische Intensivmedizin, Akademisches Lehrkrankenhaus der Universität Heidelberg, Posilipostraße 4, 71640, Ludwigsburg

    Prof. Dr. med. Ch. Wolpert

Authors
  1. Prof. Dr. med. Th. Lewalter
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prof. Dr. med. Dr. h.c. Berndt Lüderitz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dr. med. J. Schrickel
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Prof. Dr. med. Ch. Wolpert
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Lewalter, T., Lüderitz, B., Schrickel, J., Wolpert, C. (2010). Therapieverfahren. In: Herzrhythmusstörungen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-76755-8_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-76755-8_5

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-76754-1

  • Online ISBN: 978-3-540-76755-8

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation